InvestSMART

Chrysos Corporation Limited (ASX:C79)

ALERT: Price-sensitive ASX Announcement for C79
Current share price for C79 : $5.450 -3.42 (-38.56%)+
Announcement
Release
24 Nov 2025 12:35PM
Price at Release
$8.870
Full Release
download
Summary
The Chair's Address at the 2025 Chrysos Corporation Annual General Meeting highlighted the company's significant financial growth in FY25, with revenue increasing by 46% and EBITDA rising by 80%. The company expanded its global footprint by installing 11 new PhotonAssay™ units, reaching a total of 40, and signed nine new leases. Chrysos marked its entry into South America with a deployment in Chile, facilitated by a partnership with Bureau Veritas. The sustainability of the PhotonAssay™ technology was emphasized, noting its substantial environmental and safety advantages over traditional methods. Governance was bolstered with the appointment of Elisha Civil as an Independent Non-Executive Director. Looking ahead, Chrysos plans to accelerate its global roll-out, deepen partnerships, and maintain its innovation edge.
Key Points
  • Chrysos Corporation's FY25 saw a 46% increase in revenue to $66.1 million and an 80% rise in EBITDA to $16.1 million.
  • The company installed 11 new PhotonAssay™ units, bringing the total to 40 globally and signed nine new leases.
  • Chrysos expanded into South America with a deployment in Chile through a partnership with Bureau Veritas.
  • PhotonAssay™ technology offers environmental benefits, using 90% less energy and reducing CO2 emissions by 76% compared to traditional methods.
  • Governance was strengthened with the addition of Elisha Civil as an Independent Non-Executive Director.
  • Chrysos aims to accelerate global deployment, deepen customer partnerships, and sustain innovation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.